Abstract
Ovarian cancer (OC), the eighth-leading cause of cancer-related death among females worldwide, is mainly represented by epithelial OC (EOC) that can be further subdivided into four subtypes: serous (75%), endometrioid (10%), clear cell (10%), and mucinous (3%). Major reasons for high mortality are the poor biological understanding of the OC mechanisms and a lack of reliable markers defining each EOC subtype. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression primarily by targeting messenger RNA (mRNA) transcripts. Their aberrant expression patterns have been associated with cancer development, including OC. However, the role of miRNAs in tumorigenesis is still to be determined, mainly due to the lack of consensus regarding optimal methodologies for identification and validation of miRNAs and their targets. Several tools for computational target prediction exist, but false interpretations remain a problem. The experimental validation of every potential miRNA-mRNA pair is not feasible, as it is laborious and expensive. In this study, we analyzed the correlation between global miRNA and mRNA expression patterns derived from microarray profiling of 197 EOC patients to identify the signatures of miRNA-mRNA interactions associated with overall survival (OS). The aim was to investigate whether these miRNA-mRNA signatures might have a prognostic value for OS in different subtypes of EOC. The content of our cohort (162 serous carcinomas, 15 endometrioid carcinomas, 11 mucinous carcinomas, and 9 clear cell carcinomas) reflects a real-world scenario of EOC. Several interaction pairs between 6 miRNAs (hsa-miR-126-3p, hsa-miR-223-3p, hsa-miR-23a-5p, hsa-miR-27a-5p, hsa-miR-486-5p, and hsa-miR-506-3p) and 8 mRNAs (ATF3, CH25H, EMP1, HBB, HBEGF, NAMPT, POSTN, and PROCR) were identified and the findings appear to be well supported by the literature. This indicates that our study has a potential to reveal miRNA-mRNA signatures relevant for EOC. Thus, the evaluation on independent cohorts will further evaluate the performance of such findings.
Funder
Herlev Hospital
The Mermaid Foundation
Dansk Kræftforsknings Fond
Publisher
Public Library of Science (PLoS)
Reference74 articles.
1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;J Ferlay;Int J Cancer,2019
2. Ovarian cancer in the world: Epidemiology and risk factors;Z Momenimovahed;Int J Womens Health,2019
3. Cancer of the ovary, fallopian tube, and peritoneum;JS Berek;Int J Gynecol Obstet.,2018
4. Annual Report 2017–2019. Danish Gynaecologic Cancer Database (DGCD). [Internet]. 2019. Available from: http://www.dgcg.dk/images/rsrapport_DGCD_2017-19.pdf
5. The biology of ovarian cancer: New opportunities for translation;RC Bast;Nature Reviews Cancer,2009